サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1409154

成人用ワクチンの世界市場レポート 2024

Adult Vaccines Global Market Report 2024
出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 200 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.86円
成人用ワクチンの世界市場レポート 2024
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 200 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 目次
概要

成人用ワクチン市場規模は近年力強く成長しています。2023年の214億8,000万米ドルから2024年には230億9,000万米ドルへと、CAGR7.5％で拡大します。この期間に見られた成長は、高齢化人口の増加、政府主導のワクチン接種プログラム、予防ヘルスケアに対する意識の高まり、進行中のワクチン開発と技術革新、公衆衛生キャンペーンの影響など、さまざまな要因によるものです。これらの要素が総合的に成人用ワクチンの拡大と普及に貢献し、この時期の予防対策とヘルスケアへの取り組みへの関心の高まりを反映しています。

2023年の成人用ワクチン市場で最大の地域は北米でした。アジア太平洋は、予測期間中に成人用ワクチン市場で最も急成長する地域となる見込みです。当レポートの対象地域は、アジア太平洋,西欧,東欧,北米,南米,中東,アフリカです。

目次

第1章 エグゼクティブサマリー

第2章 成人用ワクチン市場の特徴

第3章 成人用ワクチン市場の動向と戦略

第4章 成人用ワクチン市場- マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界の成人用ワクチン市場の規模と成長

  • 世界の成人用ワクチン市場の促進要因と制約要因
    • 市場の促進要因
    • 市場の抑制要因
  • 世界の成人用ワクチンの市場規模の実績と成長率、2018-2023
  • 世界の成人用ワクチン市場規模と成長予測、2023-2028、2033年

第6章 成人用ワクチン市場セグメンテーション

  • 世界の成人用ワクチン市場、ワクチン別セグメンテーション、実績および予測、2018-2023、2023-2028、2033年
    • 一価
    • 多価
  • 世界の成人用ワクチン市場、技術別セグメンテーション、実績および予測、2018-2023、2023-2028、2033年
    • 弱毒化生ワクチン
    • 不活化ウイルスまたは細菌ワクチン
    • トキソイドワクチン
    • 組換えワクチン
    • 結合型ワクチン
  • 世界の成人用ワクチン市場、用途別セグメンテーション、実績および予測、2018-2023、2023-2028、2033年
    • インフルエンザ
    • 三種混合（DPT）
    • ヒトパピローマウイルス（HPV）
    • 帯状疱疹
    • 肺炎球菌
    • 肝炎
  • 世界の成人ワクチン市場、エンドユーザー別セグメンテーション、実績および予測、2018-2023、2023-2028、2033年
    • ヘルスケア企業
    • 病院

第7章 成人用ワクチン市場の地域および国分析

  • 世界の成人用ワクチン市場、地域別、実績および予測、2018-2023、2023-2028、2033年
  • 世界の成人用ワクチン市場、国別、実績および予測、2018-2023、2023-2028、2033年

第8章 アジア太平洋の成人ワクチン市場

第9章 中国成人用ワクチン市場

第10章 インドの成人用ワクチン市場

第11章 日本の成人用ワクチン市場

第12章 オーストラリアの成人用ワクチン市場

第13章 インドネシアの成人用ワクチン市場

第14章 韓国の成人用ワクチン市場

第15章 西欧の成人用ワクチン市場

第16章 英国の成人用ワクチン市場

第17章 ドイツの成人用ワクチン市場

第18章 フランスの成人用ワクチン市場

第19章 イタリアの成人用ワクチン市場

第20章 スペインの成人用ワクチン市場

第21章 東欧の成人用ワクチン市場

第22章 ロシアの成人用ワクチン市場

第23章 北米成人用ワクチン市場

第24章 米国の成人用ワクチン市場

第25章 カナダの成人用ワクチン市場

第26章 南米成人用ワクチン市場

第27章 ブラジルの成人用ワクチン市場

第28章 中東の成人用ワクチン市場

第29章 アフリカの成人用ワクチン市場

第30章 成人用ワクチン市場の競合情勢と企業プロファイル

  • 成人用ワクチン市場の競合情勢
  • 成人用ワクチン市場の企業プロファイル
    • GlaxoSmithKline PLC
    • Merck &Co
    • Sanofi Pasteur
    • Pfizer Inc
    • Commonwealth Serum Laboratories Limited

第31章 世界の成人用ワクチン市場の競合ベンチマーキング

第32章 世界の成人用ワクチン市場の競争力ダッシュボード

第33章 成人用ワクチン市場における主要な合併と買収

第34章 成人用ワクチン市場の将来展望と可能性分析

第35章 付録

目次
Product Code: r10692

“Adult Vaccines Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on adult vaccines market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for adult vaccines? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The adult vaccines market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Vaccine Type: Monovalent; Multivalent
  • 2) By Technology: Live Attenuated Vaccines; Inactivated Viral or Bacterial Vaccines; Toxoid Vaccines; Recombinant Vaccines; Conjugate Vaccines
  • 3) By Application: Influenza; DPT; Human Papillomavirus; Zoster; Pneumococcal; Hepatitis
  • 4) By End Users: Healthcare Firms; Hospitals
  • Companies Mentioned: GlaxoSmithKline PLC; Merck & Co; Sanofi Pasteur; Pfizer Inc; Commonwealth Serum Laboratories Limited
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Adult vaccines are immunizations administered to adults to stimulate an immune response against disease-causing pathogens. These vaccines play a crucial role in the prevention and treatment of various diseases affecting adults, including influenza, pneumococcal disease, and herpes.

The primary types of adult vaccines include monovalent and multivalent options. A monovalent vaccine contains the mRNA component of a single virus, triggering an immune response against a specific antigen. Various technologies are employed in the development of adult vaccines, including live attenuated vaccines, inactivated viral or bacterial vaccines, toxoid vaccines, recombinant vaccines, and conjugate vaccines. These vaccines find applications in preventing diseases such as influenza, diphtheria, pertussis, tetanus (dPT), human papillomavirus, shingles (zoster), pneumococcal disease, and hepatitis. Healthcare firms and hospitals are key users of these vaccines.

The adult vaccines market research report is one of a series of new reports from The Business Research Company that provides adult vaccines market statistics, including adult vaccines industry global market size, regional shares, competitors with a adult vaccines market share, detailed adult vaccines market segments, market trends and opportunities, and any further data you may need to thrive in the adult vaccines industry. This adult vaccines market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The adult vaccines market size has grown strongly in recent years. It will grow from $21.48 billion in 2023 to $23.09 billion in 2024 at a compound annual growth rate (CAGR) of 7.5%. The growth observed during the historical period can be attributed to various factors, including the increasing aging population, government-led vaccination programs, a growing awareness of preventive healthcare practices, ongoing vaccine development and innovation, and the impact of public health campaigns. These elements collectively contributed to the expansion and uptake of adult vaccines, reflecting a heightened focus on preventive measures and healthcare initiatives during that period.

The adult vaccines market size is expected to see strong growth in the next few years. It will grow to $32.13 billion in 2028 at a compound annual growth rate (CAGR) of 8.6%. The anticipated growth in the forecast period can be attributed to several key factors, including the emergence of new infectious threats, a heightened focus on immunization registries, the increasing threat of antimicrobial resistance, global initiatives for pandemic preparedness, a shift toward personalized vaccines, and an increased emphasis on maternal immunization. Major trends expected in the forecast period include the integration of digital health, technological advancements in vaccine production, collaborations between governments and pharmaceutical companies, innovations in vaccine delivery technologies, and the expansion of immunization programs. These trends collectively shape the evolving landscape of adult vaccines, reflecting a proactive approach to public health challenges.

The upward trajectory of the adult vaccine market is significantly influenced by the escalating prevalence of contagious diseases. Contagious diseases, which spread from person to person, underscore the critical need for vaccines in developing immunity against such illnesses. For instance, as of December 2022, the World Health Organization's COVID-19 dashboard reported 655 million COVID-19 infections since the virus emerged in 2019. Additionally, the global tuberculosis report by the World Health Organization noted a concerning rise in non-HIV-related tuberculosis deaths, escalating from 1.2 million in 2019 to 1.3 million in 2021. This surge in contagious diseases is a pivotal driver propelling the growth of the adult vaccines market.

The surge in healthcare expenditure has significantly bolstered the adult vaccine market. Healthcare expenditure encompasses the total cost of healthcare services provided to a population and often leads to amplified funding for medical research and development. Increased investments in vaccination programs and expanded access to vaccines are vital for mitigating preventable diseases and enhancing overall population health. Moreover, adult vaccination programs can yield substantial cost savings by curbing healthcare utilization and reducing the necessity for costly treatments. Notably, India's public expenditure on healthcare surged to 2.1% of GDP in 2021-22 from 1.8% in 2020-21, as highlighted in the Economic Survey of 2022. This increased healthcare expenditure has positively influenced the growth trajectory of the adult vaccine market.

Product innovation emerges as a pivotal trend driving the evolution of the adult vaccines market. Major industry players are introducing innovative products to fortify their market presence. For instance, in August 2022, GSK, a UK-based biopharma company, partnered with IQVIA, an India-based global provider of advanced analytics and clinical research services, to launch Vaccine Track. This pioneering data trend platform aims to enhance adult vaccination efforts nationwide by providing real-time, pertinent data trends that focus on improving public health initiatives. The advent of such innovative tools underscores the industry's commitment to leveraging data and technology to advance adult vaccination strategies and address prevailing healthcare challenges.

Prominent players within the adult vaccine market are emphasizing strategic collaborations aimed at the development and commercialization of personalized cancer vaccines. These collaborations, centered on mutual objectives, are pivotal business relationships between multiple companies. For instance, in October 2022, Merck & Co., Inc., an American multinational pharmaceutical company, partnered with Moderna, a US-based pharmaceutical and biotechnology company, to collectively advance and commercialize the personalized cancer vaccine mRNA-4157/V940. Under their existing collaboration and license agreement, both entities will collaborate on the development and commercialization of mRNA-4157/V940, which is currently undergoing assessment in a Phase 2 clinical trial conducted by Moderna. This vaccine is being evaluated alongside KEYTRUDA, Merck's anti-PD-1 therapy, as an adjuvant treatment for high-risk melanoma patients.

In August 2022, GSK, a UK-based pharmaceutical giant, acquired Affinivax, Inc., a US-based clinical-stage biopharmaceutical company, in a deal of undisclosed value. This strategic acquisition aligns with GSK's broader strategy of bolstering its portfolio in specialty medicines and vaccines, particularly focusing on innovative vaccine candidates for pneumococcal disease. Affinivax, Inc., known for its pioneering work in next-generation pneumococcal vaccines and adult vaccines based on the Multiple Antigen Presenting System (MAPS) platform technology, is expected to complement GSK's efforts in advancing cutting-edge vaccine solutions. This strategic move underscores GSK's commitment to driving advancements in adult vaccines and strengthening its position within the healthcare landscape.

Major companies operating in the adult vaccines market report are GlaxoSmithKline PLC, Merck & Co, Sanofi Pasteur, Pfizer Inc, Commonwealth Serum Laboratories Limited, Johnson & Johnson, Serum Institute of India, AstraZeneca PLC, Novartis AG, Protein Sciences Corporation, Emergent BioSolutions Inc., Bavarian Nordic A/S, Dynavax Technologies Corporation, Novavax Inc, Medimmune, BioNTech SE, Moderna, Inovio Pharmaceuticals, Sinovac, Valneva Se, Bharat Biotech, Biological E Limited, Panacea Biotec, Shenzhen Kangtai Biological Products, Beijing Tiantan Biological Products, Hualan Biological Engineering, Chengdu Institute of Biological Products, Bharat Biotech International Limited, Protein Sciences Corporation, Takeda Pharmaceutical Company Limited .

North America was the largest region in the adult vaccines market in 2023. Asia-Pacific is expected to be the fastest-growing region in the adult vaccines market during the forecast period. The regions covered in the adult vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the adult vaccines market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The adult vaccines market consists of sales of mRNA vaccines and viral vector vaccines. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Adult Vaccines Market Characteristics

3. Adult Vaccines Market Trends And Strategies

4. Adult Vaccines Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On the Market
  • 4.2. Ukraine-Russia War Impact On the Market
  • 4.3. COVID-19 Impact On the Market

5. Global Adult Vaccines Market Size and Growth

  • 5.1. Global Adult Vaccines Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Adult Vaccines Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Adult Vaccines Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Adult Vaccines Market Segmentation

  • 6.1. Global Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Monovalent
  • Multivalent
  • 6.2. Global Adult Vaccines Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Live Attenuated Vaccines
  • Inactivated Viral or Bacterial Vaccines
  • Toxoid Vaccines
  • Recombinant Vaccines
  • Conjugate Vaccines
  • 6.3. Global Adult Vaccines Market, Segmentation By Application , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Influenza
  • DPT
  • Human Papillomavirus
  • Zoster
  • Pneumococcal
  • Hepatitis
  • 6.4. Global Adult Vaccines Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Healthcare Firms
  • Hospitals

7. Adult Vaccines Market Regional And Country Analysis

  • 7.1. Global Adult Vaccines Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Adult Vaccines Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Adult Vaccines Market

  • 8.1. Asia-Pacific Adult Vaccines Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Adult Vaccines Market, Segmentation By Application , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Adult Vaccines Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Adult Vaccines Market

  • 9.1. China Adult Vaccines Market Overview
  • 9.2. China Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Adult Vaccines Market, Segmentation By Application , Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Adult Vaccines Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Adult Vaccines Market

  • 10.1. India Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Adult Vaccines Market, Segmentation By Application , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Adult Vaccines Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Adult Vaccines Market

  • 11.1. Japan Adult Vaccines Market Overview
  • 11.2. Japan Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Adult Vaccines Market, Segmentation By Application , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Adult Vaccines Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Adult Vaccines Market

  • 12.1. Australia Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Adult Vaccines Market, Segmentation By Application , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Adult Vaccines Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Adult Vaccines Market

  • 13.1. Indonesia Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Adult Vaccines Market, Segmentation By Application , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Adult Vaccines Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Adult Vaccines Market

  • 14.1. South Korea Adult Vaccines Market Overview
  • 14.2. South Korea Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Adult Vaccines Market, Segmentation By Application , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Adult Vaccines Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Adult Vaccines Market

  • 15.1. Western Europe Adult Vaccines Market Overview
  • 15.2. Western Europe Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Adult Vaccines Market, Segmentation By Application , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Adult Vaccines Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Adult Vaccines Market

  • 16.1. UK Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Adult Vaccines Market, Segmentation By Application , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Adult Vaccines Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Adult Vaccines Market

  • 17.1. Germany Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Adult Vaccines Market, Segmentation By Application , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Adult Vaccines Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Adult Vaccines Market

  • 18.1. France Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Adult Vaccines Market, Segmentation By Application , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Adult Vaccines Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Adult Vaccines Market

  • 19.1. Italy Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Adult Vaccines Market, Segmentation By Application , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Adult Vaccines Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Adult Vaccines Market

  • 20.1. Spain Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Adult Vaccines Market, Segmentation By Application , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Adult Vaccines Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Adult Vaccines Market

  • 21.1. Eastern Europe Adult Vaccines Market Overview
  • 21.2. Eastern Europe Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Adult Vaccines Market, Segmentation By Application , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Adult Vaccines Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Adult Vaccines Market

  • 22.1. Russia Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Adult Vaccines Market, Segmentation By Application , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Adult Vaccines Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Adult Vaccines Market

  • 23.1. North America Adult Vaccines Market Overview
  • 23.2. North America Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Adult Vaccines Market, Segmentation By Application , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Adult Vaccines Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Adult Vaccines Market

  • 24.1. USA Adult Vaccines Market Overview
  • 24.2. USA Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Adult Vaccines Market, Segmentation By Application , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Adult Vaccines Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Adult Vaccines Market

  • 25.1. Canada Adult Vaccines Market Overview
  • 25.2. Canada Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Adult Vaccines Market, Segmentation By Application , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Adult Vaccines Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Adult Vaccines Market

  • 26.1. South America Adult Vaccines Market Overview
  • 26.2. South America Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Adult Vaccines Market, Segmentation By Application , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Adult Vaccines Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Adult Vaccines Market

  • 27.1. Brazil Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Adult Vaccines Market, Segmentation By Application , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Adult Vaccines Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Adult Vaccines Market

  • 28.1. Middle East Adult Vaccines Market Overview
  • 28.2. Middle East Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Adult Vaccines Market, Segmentation By Application , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Adult Vaccines Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Adult Vaccines Market

  • 29.1. Africa Adult Vaccines Market Overview
  • 29.2. Africa Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Adult Vaccines Market, Segmentation By Application , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Adult Vaccines Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Adult Vaccines Market Competitive Landscape And Company Profiles

  • 30.1. Adult Vaccines Market Competitive Landscape
  • 30.2. Adult Vaccines Market Company Profiles
    • 30.2.1. GlaxoSmithKline PLC
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Merck & Co
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Sanofi Pasteur
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Pfizer Inc
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Commonwealth Serum Laboratories Limited
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Global Adult Vaccines Market Competitive Benchmarking

32. Global Adult Vaccines Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Adult Vaccines Market

34. Adult Vaccines Market Future Outlook and Potential Analysis

  • 34.1 Adult Vaccines Market In 2028 - Countries Offering Most New Opportunities
  • 34.2 Adult Vaccines Market In 2028 - Segments Offering Most New Opportunities
  • 34.3 Adult Vaccines Market In 2028 - Growth Strategies
    • 34.3.1 Market Trend Based Strategies
    • 34.3.2 Competitor Strategies

35. Appendix

  • 35.1. Abbreviations
  • 35.2. Currencies
  • 35.3. Historic And Forecast Inflation Rates
  • 35.4. Research Inquiries
  • 35.5. The Business Research Company
  • 35.6. Copyright And Disclaimer